New combo drug aims to ease arthritis pain without lifelong meds
NCT ID NCT05942911
First seen Apr 03, 2026 · Last updated May 15, 2026 · Updated 8 times
Summary
This study tested a new drug called IHL-675A in people with rheumatoid arthritis to see if it safely reduces pain and improves daily function. About 20 volunteers took either IHL-675A, CBD, hydroxychloroquine, or a placebo twice daily for 24 weeks. The study was stopped early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AusTrials Wellers Hill
Wellers Hill, Queensland, 4121, Australia
-
AusTrials Westside (Taringa)
Taringa, Queensland, 4068, Australia
-
Captain Sterling Medical Centre
Nedlands, Western Australia, 6009, Australia
-
Coast Joint Care
Maroochydore, Queensland, 4558, Australia
-
Emeritus Research
Sydney, New South Wales, 2019, Australia
-
Emeritus Research Melbourne
Camberwell, Victoria, 3124, Australia
-
Genesis Research Services
Broadmeadow, New South Wales, 2292, Australia
-
Novatrials
Kotara, New South Wales, 2289, Australia
-
Paratus Clinical (Woden Dermatology)
Phillip, Australian Capital Territory, 2606, Australia
-
Royal Prince Alfred Hospital
Camperdown, New South Wales, 2050, Australia
Conditions
Explore the condition pages connected to this study.